Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer

The biological and biochemical effects of estrogen have been ascribed to its known receptors, which function as ligand-inducible transcription factors. However, estrogen also triggers rapid activation of classical second messengers (cAMP, calcium, and inositol triphosphate) and stimulation of intracellular signaling cascades mitogen-activated protein kinase (MAP K), PI3K and eNOS. These latter events are commonly activated by membrane receptors that either possess intrinsic tyrosine kinase activity or couple to heterotrimeric G-proteins. We have shown that estrogen transactivates the epidermal growth factor receptor (EGFR) to MAP K signaling axis via the G-protein-coupled receptor (GPCR), GPR30, through the release of surface-bound proHB-EGF from estrogen receptor (ER)-negative human breast cancer cells [Molecular Endocrinology 14 (2000) 1649]. This finding is consistent with a growing body of evidence suggesting that transactivation of EGFRs by GPCRs is a recurrent theme in cell signaling. GPCR-mediated transactivation of EGFRs by estrogen provides a previously unappreciated mechanism of cross-talk between estrogen and serum growth factors, and explains prior data reporting the EGF-like effects of estrogen. This novel mechanism by which estrogen activates growth factor-dependent signaling and its implications for breast cancer biology are discussed further in this review.

[1]  M. S. Khan,et al.  Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  M. Beato,et al.  Steroid hormone receptors: an update. , 2000, Human reproduction update.

[3]  S. Kato,et al.  Rapid activation of MAP kinase by estrogen in the bone cell line. , 1997, Biochemical and biophysical research communications.

[4]  R. Lefkowitz,et al.  Phosphatidylinositol 3-Kinase Is an Early Intermediate in the Gβγ-mediated Mitogen-activated Protein Kinase Signaling Pathway (*) , 1996, The Journal of Biological Chemistry.

[5]  M. Beato,et al.  Control of Transcription by Steroid Hormones a , 1996, Annals of the New York Academy of Sciences.

[6]  B. Katzenellenbogen,et al.  A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. , 2000, Endocrinology.

[7]  P. Negulescu,et al.  A Nongenomic Mechanism for Progesterone-mediated Immunosuppression: Inhibition of K+ Channels, Ca2+ Signaling, and Gene Expression in T Lymphocytes , 1998, The Journal of experimental medicine.

[8]  J. Ross,et al.  The HER‐2/neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy , 1998, The oncologist.

[9]  P. Bontempo,et al.  Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells. , 1996, The EMBO journal.

[10]  J. Termine,et al.  Post-menopausal women and osteoporosis: available choices for maintenance of skeletal health. , 1998, Maturitas.

[11]  S. F. Arnold,et al.  Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase II: Consequence on DNA binding , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[12]  R. Yarden,et al.  Bimodal regulation of epidermal growth factor receptor by estrogen in breast cancer cells. , 1996, Endocrinology.

[13]  W. Rosner,et al.  Sex hormone-binding globulin receptor signal transduction proceeds via a G protein , 1999, Steroids.

[14]  J. York,et al.  Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H. Kim,et al.  Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product. , 1994, The Journal of biological chemistry.

[16]  H. Heng,et al.  Discovery of three novel G-protein-coupled receptor genes. , 1998, Genomics.

[17]  J. Lakins,et al.  Expression and regulation of estrogen receptor beta in human breast tumors and cell lines. , 2000, Oncology reports.

[18]  B. Katzenellenbogen,et al.  Antiestrogens: Mechanisms of action and resistance in breast cancer , 1997, Breast Cancer Research and Treatment.

[19]  Robert J. Lefkowitz,et al.  Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A , 1997, Nature.

[20]  B. Katzenellenbogen,et al.  Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  T. Simoncini,et al.  Raloxifene acutely stimulates nitric oxide release from human endothelial cells via an activation of endothelial nitric oxide synthase. , 2000, The Journal of clinical endocrinology and metabolism.

[22]  J. Shine,et al.  Sequence and expression of human estrogen receptor complementary DNA. , 1986, Science.

[23]  W. Sessa,et al.  Membrane Estrogen Receptor Engagement Activates Endothelial Nitric Oxide Synthase via the PI3-Kinase–Akt Pathway in Human Endothelial Cells , 2000, Circulation research.

[24]  A. Ullrich,et al.  Signal characteristics of G protein‐transactivated EGF receptor , 1997, The EMBO journal.

[25]  G. Garcı́a-Cardeña,et al.  17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization. , 1997, Circulation research.

[26]  M. Lieberherr,et al.  Phospholipase C β and Membrane Action of Calcitriol and Estradiol* , 1997, The Journal of Biological Chemistry.

[27]  B. Vanderhyden,et al.  A new, nongenomic estrogen action: the rapid release of intracellular calcium. , 1992, Endocrinology.

[28]  R. Lefkowitz,et al.  Receptor-tyrosine-kinase- and Gβγ-mediated MAP kinase activation by a common signalling pathway , 1995, Nature.

[29]  M. Duffy,et al.  Metalloproteinases: role in breast carcinogenesis, invasion and metastasis , 2000, Breast Cancer Research.

[30]  J. Massagué,et al.  Membrane-anchored growth factors. , 1993, Annual review of biochemistry.

[31]  P. L. Becker,et al.  Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[32]  A. Ebert,et al.  Expression and Function of Egf-Related Peptides and Their Receptors in Gynecological Cancer - From Basic Science to Therapy? , 2000, Journal of receptor and signal transduction research.

[33]  C. Owman,et al.  Cloning of human cDNA encoding a novel heptahelix receptor expressed in Burkitt's lymphoma and widely distributed in brain and peripheral tissues. , 1996, Biochemical and biophysical research communications.

[34]  A. Ullrich,et al.  Tyrosine kinase signalling in breast cancer: Epidermal growth factor receptor - convergence point for signal integration and diversification , 2000, Breast Cancer Research.

[35]  D. Slamon,et al.  HER-2/neu oncogene amplification and expression in breast and ovarian cancers. , 1990, Progress in clinical and biological research.

[36]  J. Massagué.  TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[37]  B. Neel,et al.  New Role for Shc in Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway , 2000, Molecular and Cellular Biology.

[38]  J. Wittliff.  Steroid‐hormone receptors in breast cancer , 1984, Cancer.

[39]  P. Crespo,et al.  Linkage of G Protein-Coupled Receptors to the MAPK Signaling Pathway Through PI 3-Kinase γ , 1997, Science.

[40]  M. S. Khan,et al.  Biologically active steroids activate receptor-bound human sex hormone-binding globulin to cause LNCaP cells to accumulate adenosine 3',5'-monophosphate. , 1990, The Journal of clinical endocrinology and metabolism.

[41]  B. Berk,et al.  Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors. , 2001, Journal of molecular and cellular cardiology.

[42]  P. Shaul.  Novel role of estrogen receptors in vascular endothelium. , 2000, Seminars in perinatology.

[43]  J. Polman,et al.  ERβ: Identification and characterization of a novel human estrogen receptor , 1996 .

[44]  J. Ando,et al.  Cloning of cDNAs encoding G protein-coupled receptor expressed in human endothelial cells exposed to fluid shear stress. , 1997, Biochemical and biophysical research communications.

[45]  Richard G. W. Anderson,et al.  Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. , 2000, Circulation research.

[46]  D. Lannigan,et al.  Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. , 1995, Molecular endocrinology.

[47]  P. Crespo,et al.  Dual Effect of β-Adrenergic Receptors on Mitogen-activated Protein Kinase , 1995, The Journal of Biological Chemistry.

[48]  E. Krebs,et al.  Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. , 1997, Endocrinology.

[49]  U. Gether.  Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. , 2000, Endocrine reviews.

[50]  M. Lieberherr,et al.  Progesterone triggers rapid transmembrane calcium influx and/or calcium mobilization from endoplasmic reticulum, via a pertussis‐insensitive G‐protein in granulosa cells in relation to luteinization process , 1996, Journal of cellular biochemistry.

[51]  K. Bland,et al.  Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. , 2000, Molecular endocrinology.

[52]  R. Lefkowitz,et al.  G-protein-coupled receptors and their regulation: activation of the MAP kinase signaling pathway by G-protein-coupled receptors. , 1997, Advances in second messenger and phosphoprotein research.

[53]  F. Wunderlich,et al.  Estradiol Signaling via Sequestrable Surface Receptors. , 2001, Endocrinology.

[54]  Joseph Schlessinger,et al.  A Novel Positive Feedback Loop Mediated by the Docking Protein Gab1 and Phosphatidylinositol 3-Kinase in Epidermal Growth Factor Receptor Signaling , 2000, Molecular and Cellular Biology.

[55]  J. Guzzo.  Selective estrogen receptor modulators—A new age of estrogens in cardiovascular disease? , 2000, Clinical cardiology.

[56]  L. Cantley,et al.  ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor , 1994, Molecular and cellular biology.

[57]  C. Hermenegildo,et al.  The endometrial effects of SERMs. , 2000, Human reproduction update.

[58]  C. Rosenfeld,et al.  Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. , 1997, The American journal of physiology.

[59]  G. Nuovo,et al.  Hyperexpression of mitogen-activated protein kinase in human breast cancer. , 1997, The Journal of clinical investigation.

[60]  M. Maa,et al.  c-Src-mediated Phosphorylation of the Epidermal Growth Factor Receptor on Tyr845 and Tyr1101 Is Associated with Modulation of Receptor Function* , 1999, The Journal of Biological Chemistry.

[61]  R. Weigel,et al.  Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. , 1997, Genomics.

[62]  M. Mendelsohn.  Nongenomic, ER-mediated activation of endothelial nitric oxide synthase: how does it work? What does it mean? , 2000, Circulation research.

[63]  K. Korach,et al.  Influence of estrogens on mouse uterine epidermal growth factor precursor protein and messenger ribonucleic acid. , 1988, Endocrinology.

[64]  E. Smeland,et al.  A novel putative G‐protein‐coupled receptor expressed in lung, heart and lymphoid tissue , 1997, FEBS letters.

[65]  N. Hynes,et al.  Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling , 1995, Molecular and cellular biology.

[66]  B. Katzenellenbogen,et al.  Nuclear hormone receptors: ligand-activated regulators of transcription and diverse cell responses. , 1996, Chemistry & biology.

[67]  H. Kawakatsu,et al.  Calcium-dependent Epidermal Growth Factor Receptor Transactivation Mediates the Angiotensin II-induced Mitogen-activated Protein Kinase Activation in Vascular Smooth Muscle Cells* , 1998, The Journal of Biological Chemistry.

[68]  Zbigniew Dauter,et al.  Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.

[69]  J. Thornton,et al.  Identification of a third distinct estrogen receptor and reclassification of estrogen receptors in teleosts. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[70]  S. Dey,et al.  Differential expression of epidermal growth factor receptor (EGF-R) gene and regulation of EGF-R bioactivity by progesterone and estrogen in the adult mouse uterus. , 1994, Endocrinology.

[71]  E. Jensen,et al.  Estrogen-Receptor Interaction , 1973, Science.

[72]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[73]  P. Hurn,et al.  Estrogen as a Neuroprotectant in Stroke , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[74]  V. Mukku,et al.  Regulation of epidermal growth factor receptor by estrogen. , 1985, The Journal of biological chemistry.

[75]  D. Stern.  Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases , 2000, Breast Cancer Research.

[76]  Daniel Metzger,et al.  Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase , 1995, Science.

[77]  R. Wetzker,et al.  An Epidermal Growth Factor Receptor/Gab1 Signaling Pathway Is Required for Activation of Phosphoinositide 3-Kinase by Lysophosphatidic Acid* , 1999, The Journal of Biological Chemistry.

[78]  H. Kung,et al.  Activated type I phosphatidylinositol kinase is associated with the epidermal growth factor (EGF) receptor following EGF stimulation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[79]  M. Lieberherr,et al.  Gαq/11 and Gβγ proteins and membrane signaling of calcitriol and estradiol , 1999 .

[80]  Y. Yarden,et al.  A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor , 1996, Molecular and cellular biology.

[81]  W. Hung,et al.  Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells , 2000, Oncogene.

[82]  R. Lefkowitz,et al.  Regulation of tyrosine kinase cascades by G-protein-coupled receptors. , 1999, Current opinion in cell biology.

[83]  K. Nelson,et al.  Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[84]  B. Dufy,et al.  17β-Estradiolid Ca influx rapid Ca2+ prostate cancer cells , 1996 .

[85]  P. Gregor,et al.  Cloning of a novel member of the G protein-coupled receptor family related to peptide receptors. , 1997, Biochemical and biophysical research communications.